Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 28, 1095-1109, June 1, 1968]
© 1968 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hunt, D. E.
Right arrow Articles by Pittillo, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hunt, D. E.
Right arrow Articles by Pittillo, R. F.

Determination of Certain Antitumor Agents in Mouse Blood by Microbiologic Assay1

Dale E. Hunt and Robert F. Pittillo

Kettering-Meyer Laboratories, Southern Research Institute,2 Birmingham, Alabama 35205

Microbiologic assays have been adapted or developed for the estimation of certain antitumor compounds (or cytotoxic equivalents) in biologic tissues. Sufficiently sensitive assay procedures for measuring blood concentrations following realistic therapeutic doses in mice are described for 6-methylmercaptopurine riboside (NSC 40774), 5-fluorouracil (NSC 19893), 5-fluorodeoxyuridine (NSC 27640), Methotrexate (NSC 740), and actinobolin (NSC 31083). Less sensitive, but sometimes useful, assay procedures are described for 6-mercaptopurine (NSC 755), 6-mercaptopurine riboside (NSC 4911), and 2-chloro-4',4''-di-2-imidazolin-2-yl, terephthalanilide (NSC 60339). Assay procedures for actinomycin D (NSC 3053) and 1,3-bis(2-chloroethyl)-1-nitrosourea [BCNU] (NSC 409962) are presented; however, the latter two assays lack sufficient sensitivity to measure nonlethal doses of drug.

1 This work was supported by the Cancer Chemotherapy National Service Center, National Cancer Institute under NIH Contract Number PH43-65-594.

2 Affiliated with Sloan-Kettering Institute for Cancer Research, New York.

Received 11/ 6/67. Accepted 2/19/68.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1968 by the American Association for Cancer Research.